Literature DB >> 31438729

Negative association between serum adropin and hypertensive disorders complicating pregnancy.

Dong Lin1, Jian Yong1, Shuhua Ni1, Weichao Ou2, Xuerui Tan1.   

Abstract

Objective: Study the association of adropin and hypertensive disorders complicating pregnancy (HDCP).
Methods: Patients with HDCP were matched with normotensive women (47 pairs). Adropin concentrations were detected by enzyme-linked immunosorbent assay.
Results: Compared with the controls, the serum adropin levels were lower in the HDCP group (P < 0.001) and in HDCP subgroups (gestational hypertension, mild preeclampisa, and severe preeclampsia, term, preterm, early onset, and late onset) (all P < 0.05). After adjustment for confounders, adropin remained negatively associated with HDCP (P = 0.027).
Conclusion: Lower adropin concentration is significantly associated with HDCP, suggesting that higher or normal adropin levels may be protective against HDCP.

Entities:  

Keywords:  Adropin; hypertension; hypertensive disorders complicating pregnancy; pre-eclampsia; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31438729     DOI: 10.1080/10641955.2019.1657887

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  4 in total

1.  Association between adropin and coronary artery lesions in children with Kawasaki disease.

Authors:  Maoling Yang; Qiongfei Pei; Jing Zhang; Haobo Weng; Fengchuan Jing; Qijian Yi
Journal:  Eur J Pediatr       Date:  2021-03-13       Impact factor: 3.183

Review 2.  Adropin as A Fat-Burning Hormone with Multiple Functions-Review of a Decade of Research.

Authors:  Mariami Jasaszwili; Maria Billert; Mathias Z Strowski; Krzysztof W Nowak; Marek Skrzypski
Journal:  Molecules       Date:  2020-01-27       Impact factor: 4.411

3.  Serum Expression of ESM-1, HMWA, and AGEs and Its Relationship with Disease Severity in Patients with Gestational Hypertension.

Authors:  Yun Yan; Linlin Luan; Jieru Xu
Journal:  Comput Math Methods Med       Date:  2021-12-09       Impact factor: 2.238

4.  Optimal therapeutic adropin dose intervention in mice and rat animal models: A systematic review.

Authors:  Foad Alzoughool; Mohammad Borhan Al-Zghoul
Journal:  Vet World       Date:  2021-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.